Ronald W. Penczek
At a glance: Ronald W. Penczek is Cao & Controller at Elevance Health (ELV). Their latest SEC Form 4, filed Jun 15, 2026, reported a sale of $149K. On file: 0 purchase lines ($0) and 2 sale lines ($766K).
Disclosed holdings: about $1.5M of ELV stock: 3,740 shares reported on their latest Form 4 (filed Jun 15, 2026), valued at the Nov 19, 2026 close of $391.13. This counts only ELV shares reported to the SEC; it leaves out cash, other investments, options and unvested awards, so it is not total net worth.
Cao & Controller at Elevance Health, Inc. (ELV)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
Ronald W. Penczek's InsiderPrint
2 trades from SEC Form 4 filings, 2026 to 2026, drawn as one fingerprint.
- Bump outward: a purchase (0)
- Dent inward: a sale (2)
- One ring per year, oldest in the middle, Jan at the top going clockwise. Bigger bumps mean more dollars.
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Jun 15SEC | ELVElevance Health, Inc. | Sell | 3693,740 held (−9%) | $403.16 | $149K | -3.0% |
| May 20SEC | ELVElevance Health, Inc. | Sell | 1,5314,109 held (−27%) | $403.13 | $617K | -3.0% |
- Sell
Cao & Controller Ronald W Penczek sold $617K of ELV at $403.13 — cuts the stake by 27%.
Follow Ronald W. Penczek
Get one email when Ronald W. Penczek files a new purchase or sale. Free.
At most one email a day about Ronald W. Penczek, plus the free Monday email. Already subscribed? Use the same email to add them. Unsubscribe anytime. Facts from public filings, not advice.